Use of the ganciclovir implant in the treatment of recurrent cytomegalovirus retinitis

Archives of Ophthalmology

Volumn 114, Issue 7, 1996, Pages 815-820

  Marx, Jeffrey L ^a   Kapusta, Michael A ^a   Patel, Sunil S ^a   LaBree, Laurie D ^a   Walonker, Francis ^a   Rao, Narsing A ^a   Chong, Lawrence P ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b DOHENY EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR;

ADOLESCENT; ADULT; ARTICLE; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; HYPHEMA; IMPLANTATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PATIENT SELECTION; PRIORITY JOURNAL; RECURRENT DISEASE; RETINA DETACHMENT; RETINITIS; RETROSPECTIVE STUDY; SCHOOL CHILD; STATISTICAL ANALYSIS; VITREOUS HEMORRHAGE;

EID: 0030004075     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1996.01100140029003     Document Type: Article

References (28)

1. Holland GN, Pepose JS, Pettit TH, Gottlieb MS, Yee RD, Foos RY. Acquired immune deficiency syndrome: ocular manifestations. Ophthalmology. 1983; 90:859-873.
2. Palestine AG, Rodrigues MM, Macher AM, et al. Ophthalmic involvement in acquired immunodeficiency syndrome. Ophthalmology. 1984;91:1092-1099.
3. Pepose JS, Holland GN, Nestor MS, Cochran AJ, Foos RY. Acquired immune deficiency syndrome: pathogenic mechanisms of ocular disease. Ophthalmology. 1985;92:472-484.
4. Jabs DA, Green WR, Fox R., Folk BF, Bartlett JG. Ocular manifestations of acquired immune deficiency syndrome. Ophthalmology. 1989;96:1092-1099.
5. Gross JG, Bozette SA, Mathews WC, et al. Longitudinal study of cytomegalvirus retinitis in acquired immune deficiency syndrome. Ophthalmology. 1990;97:681-686.
6. Orellana J, Teich SA, Friedman AH, Lerebours F, Winterkonn J, Mildvan D. Combined short- and long-term therapy for the treatment of cytomegalovirus retinitis using ganciclovir (BW B759U). Ophthalmology. 1987;94:831-838.
7. Jabs DA, Newman C, de Bustros S, Polk BF. Treatment of cytomegalovirus retinitis with ganciclovir. Ophthalmology. 1987;94:824-830.
8. Holland GN, Sidikaro Y, Kreiger AE, et al. Treatment of cytomegalovirus retinopathy with ganciclovir. Ophthalmology. 1987;94:815-823.
9. Henderly DE, Freeman WR, Causey DM, Rao NA. Cytomegalovirus retinitis and response to therapy with ganciclovir. Ophthalmology. 1987;94:425-434.
10. Holland GN, Buhles WC Jr, Mastre B, Kaplan HJ, UCLA CMV Retinopathy Study Group. A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy: use of a standardized system for the assessment of disease outcome. Arch Ophthalmol. 1989;107:1759-1766.
11. LeHoang P, Girard B, Robinet M, et al. Foscarnet in the treatment of cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology. 1989;96:865-873.
12. Palestine AG, Polis MA, DeSmet MD, et al. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann Intern Med. 1991;115:665-673.
13. Holland GN, Shuler JD. Progression rates of cytomegalovirus retinopathy in ganciclovir-treated and untreated patients. Arch Ophthalmol. 1992;110:1435-1442.
14. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. Foscamet-Gancicloivir Cytomegalovirus Retinitis Trial, 4: visual outcomes. Ophthalmology. 1994;101:1250-1261.
15. Kuppermann BD, Flores-Aguilar M, Quiceno JI, Rickman LS, Freeman WR. Combination ganciclovir and foscarnet in the treatment of clinically resistant cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Arch Ophthalmol. 1993;111:1359-1366.
16. Henry K, Cantrill H, Fletcher C. Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS. Am J Ophthalmol. 1987;103:17-23.
17. Ussery FM III, Gibson SR, Conklin RH, Piot DF, Stool EW, Conklin AJ. Intravitreal ganciclovir in the treatment of AIDS-associated cytomegalovirus retinitis. Ophthalmology. 1988;95:640-648.
18. Cantrill HL, Henry K, Melroe NH, Knobloch WH, Ramsay RC, Balfour HH. Treatment of cytomegalovirus retinitis with intravitreal ganciclovir: long-term results. Ophthalmology. 1989;96:367-374.
19. Diaz-Llopis M, Chipont E, Sanchez S, Espana E, Navea A, Menezo JL. Intravitreal foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome. Am J Ophthalmol. 1992;114:742-747.
20. Heinemann M-H. Long-term intravitreal ganciclovir therapy for cytomegalovirus retinopathy. Arch Ophthalmol. 1989;107:1767-1772.
21. Sanborn GE, Anand R, Torti RE, et al. Sustained-release ganciclovir therapy for treatment of cytomegalovirus retinopathy: use of an intravitreal device. Arch Ophthalmol. 1992;110:188-195.
22. Anand R, Nightingale SD, Fish RH, Smith TJ, Ashton P. Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir. Arch Ophthalmol. 1993;111:223-227.
23. Smith TJ, Pearson PA, Blandford DL, et al. Intravitreal sustained-release ganciclovir. Arch Ophthalmol. 1992;110:255-258.
24. Martin DF, Parks DJ, Mellow SD, et al. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. Arch Ophthalmol. 1994; 112:1531-1539.
25. Freeman WR, Henderly DE, Wan WL, et al. Prevalence, pathophysiology, and treatment of rhegmatogenous retinal detachment in treated cytomegalovirus retinitis. Am J Ophthalmol. 1986;103:527-536.
26. Jabs DA, Enger C, Haller J, de Bustros S. Retinal detachments in patients with cytomegalovirus retinitis. Arch Ophthalmol. 1991;109:794-799.
27. Sidikaro Y, Silver L, Holland GN, Kreiger AE. Rhegmatogenous retinal detachments in patients with AIDS and necrotizing retinal infections. Ophthalmology. 1991;98:129-135.
28. Freeman WR, Friedberg DN, Berry C. Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis. Am J Ophthalmol. 1993;116:713-720.